VRTX · Forms 3, 4, 5
Insider trades at VERTEX PHARMACEUTICALS INC / MA
No open-market insider buys or sells at VERTEX PHARMACEUTICALS INC / MA in the last 90 days; 6 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for VERTEX PHARMACEUTICALS INC / MA (VRTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Grunsven Jasper van | EVP, CP and NPPO | Became an insider (Form 3) | Form 3 | ||||
| Grunsven Jasper van | EVP, CP and NPPO | Award | 8,682 | Form 4 | |||
| Kristen Ambrose | SVP & Chief Accounting Officer | Award | 5,000 | Form 4 | |||
| Bruce I Sachs | Director | Gift | 6,000 | Form 4 | |||
| Ourania Tatsis | EVP, Chief Reg. & Quality Off. | Award | 8,251 | Form 4 | |||
| Amit Sachdev | EVP Chief Patient & Ext Af Off | Award | 8,251 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.